Wealthfront Advisers LLC Makes New $845,000 Investment in Trupanion, Inc. (NASDAQ:TRUP)

Wealthfront Advisers LLC acquired a new position in shares of Trupanion, Inc. (NASDAQ:TRUP) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 17,529 shares of the financial services provider’s stock, valued at approximately $845,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of TRUP. SBI Securities Co. Ltd. acquired a new stake in Trupanion during the 4th quarter worth about $25,000. Jones Financial Companies Lllp raised its holdings in Trupanion by 71.7% during the 4th quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock worth $27,000 after buying an additional 238 shares during the period. Quest Partners LLC acquired a new stake in Trupanion during the 3rd quarter worth about $37,000. Wilmington Savings Fund Society FSB acquired a new stake in Trupanion during the 3rd quarter worth about $54,000. Finally, KBC Group NV acquired a new position in shares of Trupanion in the 4th quarter valued at about $75,000.

Insiders Place Their Bets

In other Trupanion news, CFO Fawwad Qureshi sold 1,373 shares of the company’s stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total transaction of $46,984.06. Following the completion of the sale, the chief financial officer now owns 2,416 shares of the company’s stock, valued at $82,675.52. This represents a 36.24 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Brenna Mcgibney sold 5,000 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $32.99, for a total value of $164,950.00. Following the sale, the insider now directly owns 3,738 shares of the company’s stock, valued at $123,316.62. The trade was a 57.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 25,984 shares of company stock valued at $850,362 over the last 90 days. 5.50% of the stock is currently owned by company insiders.

Trupanion Trading Up 5.0 %

NASDAQ:TRUP opened at $35.26 on Friday. The stock’s 50 day moving average price is $42.63 and its 200 day moving average price is $47.05. Trupanion, Inc. has a 52 week low of $19.69 and a 52 week high of $57.90. The company has a market capitalization of $1.50 billion, a P/E ratio of -153.30, a P/E/G ratio of 6.02 and a beta of 1.70. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The company had revenue of $337.31 million for the quarter, compared to the consensus estimate of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. On average, research analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Stifel Nicolaus dropped their target price on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a report on Thursday, February 20th. Piper Sandler dropped their target price on Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $46.60.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.